Bruce D Weintraub

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Trophogen Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health. Active years: 2000-2020.

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 78.6

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 68(Granted Patents)

Location History:

North Potomac, MD (US) (2011)
Rockville, MD (US) (2000 - 2020)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

1 out of 1,217

The United States of America as Represented by the Department of Health

patents

Years Active: 2000-2020

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10766941 - Glycoprotein hormone long-acting superagonists (2020-09-08),

2. 10544200 - Glycoprotein hormone long-acting superagonists (2020-01-28),

3. 10457713 - Glycoprotein hormone long-acting superagonists (2019-10-29),

4. 9249205 - Glycoprotein hormone long-acting superagonists (2016-02-02),

5. 9187545 - Glycoprotein hormone long-acting superagonists (2015-11-17),

6. 9078860 - VEGF analogs (2015-07-14),

7. 8759285 - VEGF superagonists and methods of use (2014-06-24),

8. 8377879 - Follicle stimulating hormone superagonists (2013-02-19),

9. 8044187 - Human luteinizing hormone superagonists (2011-10-25),

10. 7687610 - Human chorionic gonadotropin superagonists (2010-03-30),

11. 7070788 - Follicle stimulating hormone superagonists (2006-07-04),

12. 6361992 - Thyroid stimulating hormone superagonists (2002-03-26),

13. 6284491 - Biologically active synthetic thyrotropin and cloned gene for producing same (2001-09-04),

14. 6117991 - Biologically active synthetic thyrotropin and cloned gene producing same (2000-09-12),

Title: The Innovations of Bruce D. Weintraub

Introduction

Bruce D. Weintraub is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of glycoprotein hormones, holding a total of 14 patents. His work focuses on developing long-acting, superactive analogs that enhance bioactivity, which can be crucial for various medical applications.

Latest Patents

One of his latest patents involves glycoprotein hormone long-acting superagonists. This invention provides long-acting, superactive analogs of glycoprotein hormones that demonstrate enhanced bioactivity both in vitro and in vivo compared to their wild type counterparts. These analogs are particularly useful for treating subjects with low receptor expression or poor receptor responsiveness, as well as for addressing any condition associated with glycoprotein hormone activity.

Career Highlights

Throughout his career, Bruce has worked with prominent organizations such as Trophogen Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute significantly to the advancement of medical science.

Collaborations

Bruce has collaborated with notable individuals in his field, including Mariusz Szkudlinski and Mariusz W. Szkudlinski. These collaborations have likely enriched his research and development efforts.

Conclusion

Bruce D. Weintraub's innovative work in glycoprotein hormones has the potential to impact medical treatments significantly. His extensive patent portfolio and collaborations highlight his dedication to advancing healthcare solutions.